Last update 06 Nov 2024
HH-2710
Last update 06 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HH 2710 |
Target |
Mechanism ERK1 inhibitors(Extracellular-signal-regulated kinase1 inhibitors), ERK2 inhibitors(Extracellular-signal-regulated kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HH-2710一项评估HH2710在晚期肿瘤患者中的安全性、耐受性以及药代动力学的首次人体、开放的Ⅰ/Ⅱ期研究
[Translation] A first-in-human, open-label, Phase I/II study evaluating the safety, tolerability, and pharmacokinetics of HH2710 in patients with advanced tumors
A First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patients With Advanced Tumors
100 Clinical Results associated with HH-2710
Login to view more data
100 Translational Medicine associated with HH-2710
Login to view more data
100 Patents (Medical) associated with HH-2710
Login to view more data
100 Deals associated with HH-2710
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 2 | US | 23 Jan 2020 | |
| Advanced cancer | Phase 2 | US | 23 Jan 2020 | |
| Erdheim-Chester Disease | Phase 2 | US | 23 Jan 2020 | |
| Erdheim-Chester Disease | Phase 2 | CN | 23 Jan 2020 | |
| Melanoma | Phase 2 | US | 23 Jan 2020 | |
| Melanoma | Phase 2 | CN | 23 Jan 2020 | |
| Non-Small Cell Lung Cancer | Phase 2 | US | 23 Jan 2020 | |
| Non-Small Cell Lung Cancer | Phase 2 | CN | 23 Jan 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free